Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 4Recruiting 4Completed 4Not yet recruiting 3Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1CNS 1

Conditions

Pelvic Neoplasms 1Glioblastoma 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Re-Irradiation × Clear all
NCT06397573 2026-02-17

Ablative Stereotactic MR-Guided Adaptive Reirradiation

Baptist Health South Florida

Phase NA Active not recruiting
10 enrolled
Gynecologic

Pelvic Neoplasms

NCT03743662 2026-01-07

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
39 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡